Lancet 2003, 361:512–519.PubMedCrossRef 17. Parvez S, Malik KA, Ah Kang S, Kim HY: Probiotics and their fermented food products are beneficial for health. J Appl Microbiol 2006, 100:1171–1185.PubMedCrossRef 18. Farnworth ER: The evidence to support health claims for probiotics. J Nutr 2008,138(suppl):1250–1254. 19. Cummings JH, Macfarlane GT, Englyst HN: Prebiotic digestion and fermentation. Am J Clin Nutr 2001,73(suppl):415–420. 20. Gibson GR: Dietary modulation of the human gut microflora using prebiotics. Br J Nutr 1998,80(suppl):209–212. 21. Goetze O, Fruehauf H, Pohl D, Giarrè M, Rochat F, Ornstein K, Menne D, Fried M, Thumshirn M: Effect of a prebiotic mixture
on intestinal comfort and general selleck inhibitor wellbeing in health. Br J Nutr 2008, 100:1077–1085.PubMedCrossRef 22. Suau A, Bonnet R, Sutren M, Godon JJ, Gibson GR, Collins MD, Doré J: Direct analysis of genes encoding 16S rRNA
from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 1999, 65:4799–4807.PubMed 23. Vanhoutte T, De Preter V, De Brandt E, Verbeke K, Swings J, Huys G: Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and Saccharomyces boulardii . Appl Environ Microbiol 2006, 72:5990–5997.PubMedCrossRef 24. Andersson AF, Lindberg M, Jakobsson H, Bäckhed F, Nyrén P, Engstrand Selleckchem NVP-HSP990 L: Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One 2008, 3:e2836.PubMedCrossRef 25. Armougom F, Raoult D: Use of pyrosequencing and DNA barcodes to monitor Galeterone variations in Firmicutes and Bacteroidetes communities in the gut microbiota of obese humans. BMC Genomics 2008, 9:576.PubMedCrossRef 26. Tannock GW, Munro K, Bibiloni R, Simon MA, Hargreaves P, Gopal P, Harmsen H, Welling G: Impact of consumption of oligosaccharide-containing biscuits on the fecal microbiota of humans. Appl Environ Microbiol 2004, 70:2129–2136.PubMedCrossRef 27. Malinen E, Kassinen A, Rinttilä
T, Palva A: Comparison of real-time PCR with SYBR Green I or 5′-nuclease VX-661 concentration assays and dot-blot hybridization with rDNA-targeted oligonucleotide probes in quantification of selected faecal bacteria. Microbiology 2003, 149:269–277.PubMedCrossRef 28. Bartosch S, Fite A, Macfarlane GT, McMurdo ME: Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 2004, 70:3575–3581.PubMedCrossRef 29. Matsuki T, Watanabe K, Fujimoto J, Kado Y, Takada T, Matsumoto K, Tanaka R: Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol 2004, 70:167–173.PubMedCrossRef 30.